Genomic mapping identifies multiple therapeutic pathways in malignant mesothelioma (original) (raw)
Diagnostic, prognostic, and therapeutic implications of genetic profiling in pleural mesothelioma
Raphael Bueno, Journal of Cancer Metastasis and Treatment, Ahmed Sadek
Journal of Cancer Metastasis and Treatment, 2023
View PDFchevron_right
Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
Oluf Dimitri Røe
Lung Cancer, 2010
View PDFchevron_right
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
Deborah Morris-Rosendahl
Scientific Reports
View PDFchevron_right
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration
Robert Taub
Cancer Biology & Therapy, 2016
View PDFchevron_right
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
David Gibbs
Cancer discovery, 2018
View PDFchevron_right
Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
A. Heguy, Chandra Goparaju
Cancer Research, 2014
View PDFchevron_right
Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
Ralph Schmid
Frontiers in Oncology, 2020
View PDFchevron_right
Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling
Roderick Jensen
The American Journal of Pathology, 2005
View PDFchevron_right
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives from Preclinical and Clinical Studies
Antonio Daga, Federica Barbieri
View PDFchevron_right
Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS
Sang-we Kim
Translational oncology, 2018
View PDFchevron_right
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
Federica Grosso
Cancers, 2020
View PDFchevron_right
Data from Co-occurring Mutations of Tumor Suppressor Genes, <i>LATS2</i> and <i>NF2</i>, in Malignant Pleural Mesothelioma
Didier Jean
2023
View PDFchevron_right
Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma
Jessica zucman-rossi
Clinical cancer research : an official journal of the American Association for Cancer Research, 2016
View PDFchevron_right
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma
Ralph Schmid
Cancers, 2020
View PDFchevron_right
Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype
Oluf Dimitri Røe
PLoS ONE, 2009
View PDFchevron_right
Advances in the biology of malignant pleural mesothelioma
Matteo Simonelli
Cancer Treatment Reviews, 2011
View PDFchevron_right
Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas
Nathália Campanella
Pathobiology
View PDFchevron_right
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas
Pedro Mendez
Oncotarget, 2016
View PDFchevron_right
Recent insights emerging from malignant mesothelioma genome sequencing
Michele Carbone
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015
View PDFchevron_right
Abstract 112: Genetic alterations in molecular tumor subgroups of malignant pleural mesothelioma
Didier Jean
Cancer Research, 2016
View PDFchevron_right
Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge
DAVID MICHAEL ABBOTT
Cancers, 2020
View PDFchevron_right
Genomic events associated with progression of pleural malignant mesothelioma
Michele Carbone
International Journal of Cancer, 2009
View PDFchevron_right
Molecular Targets in Malignant Pleural Mesothelioma Treatment
Giulia Pasello
Current Drug Targets, 2009
View PDFchevron_right
P53 Modeling as a Route to Mesothelioma Patients Stratification and Novel Therapeutic Identification
Constantinos Demonacos
Journal of translational medicine, 2018
View PDFchevron_right
Transcriptome sequencing of malignant pleural mesothelioma tumors
Neil Miller
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment
Didier Jean
Archives of Pathology & Laboratory Medicine, 2012
View PDFchevron_right
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
Didier Jean
Nature Genetics
View PDFchevron_right
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Ralph Schmid
Cell Death Discovery
View PDFchevron_right
Therapies currently in Phase II trials for malignant pleural mesothelioma
Daniela D Tavian
Expert Opinion on Investigational Drugs, 2013
View PDFchevron_right
Second Generation Sequencing of the Mesothelioma Tumor Genome
Bruce Taillon
PLoS ONE, 2010
View PDFchevron_right